A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents-Reference-Cited by-同舟云学术

A perspective on prognostic models in chronic lymphocytic leukemia in the era of targeted agents

Published:2021-10 Issue:5 Volume:39 Page:595-604
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Molica Stefano¹^ORCID,Seymour John F.²,Polliack Aaron³

Affiliation:

1. Department Hematology‐Oncology Azienda Ospedaliera Pugliese‐Ciaccio Catanzaro Italy

2. Department of Haematology Peter MacCallum Cancer Centre Royal Melbourne Hospital University of Melbourne Melbourne Victoria Australia

3. Department of Hematology Hadassah – Hebrew University Medical Center Jerusalem Israel

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2929

Reference86 articles.

1. Clinical staging of chronic lymphocytic leukemia

2. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

3. Chronic lymphocytic leukemia prognostic models in real life: still a long way off

4. Prognostic models for newly‐diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta‐analysis;Kreuzberger N;Cochrane Database Syst Rev,2020

5. Treatment of Chronic Lymphocytic Leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Prognostic Models Should We Use in CLL?;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Consensus Statements Highlight the Need of Harmonizing Chronic Lymphocytic Leukemia Management Worldwide;Acta Haematologica;2023-08-07

3. Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital;Acta Oncologica;2023-03-04

4. Prognostic models predicting overall survival of chronic lymphocytic leukemia (CLL) patients treated with ibrutinib-based therapies: a systematic review and meta-analysis;Leukemia & Lymphoma;2023-02-27

5. Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three‐factor model;American Journal of Hematology;2022-02-25